Comparison of different treatment approaches of pediatric chronic non-bacterial osteomyelitis

被引:0
|
作者
Mikhail M. Kostik
Olga L. Kopchak
Irina A. Chikova
Eugenia A. Isupova
Alexander Y. Mushkin
机构
[1] Saint-Petersburg State Pediatric Medical University,
[2] Kirov’s Regional Children’s Hospital,undefined
[3] Science Research Institute of Phthisiopulmonology,undefined
来源
Rheumatology International | 2019年 / 39卷
关键词
Chronic non-bacterial osteomyelitis; Pamidronate; TNFα-inhibitors;
D O I
暂无
中图分类号
学科分类号
摘要
Chronic non-bacterial osteomyelitis (CNO) is a chronic inflammatory bone disease which usually manifests in children and adolescents. There are a few data about pathogenesis and treatment. The aim of the study to compare the efficacy of different treatment approaches in pediatric CNO cohort patient. Fifty two children (25 boys and 27 girls) with CNO with average age at the onset of the disease 8.4 years (5.4; 11.0), number of foci − 3.0 (2.0; 6.0, incl. multifocal cases in 80.8%). Non-steroid anti-inflammatory drugs (NSAID) was the first-line treatment for non-vertebral cases, as well as pamidronate (PAM) for vertebral involvement. Second-line treatment includes sulfasalazine (SSZ), methotrexate (MTX), PAM and tumor necrosis factor-α inhibitors (TNFα-inh). We evaluated the dynamics of pain, patient’s and physician’s (MDVAS) assessment with visual-analog scale (VAS) and ability to each medication to achieve remission of CNO activity. According to the NSAID, MTX, SSZ, PAM and TNFα-inh groups the following data were registered: patient’s VAS: − 14.2% (p = 0.05), − 50.0% (p = 0.04), − 23.1 (p = 0.89), − 83.3% (p = 0.0001), − 73.6% (p = 0.0007); painVAS: − 21.9% (p = 0.01), − 18.6% (p = 0.13), + 36.4 (p = 0.89), − 79.7% (p = 0.00016), − 74.1%, (p = 0.0015); MDVAS: − 13.8% (p = 0.13); − 56.4% (p = 0.09), + 30.8% (p = 0.89), − 74.7%, (p = 0.0001), − 82.1 (p = 0.0015) respectively. The ability of each treatment strategy to achieve the CNO remission was 52.6%, 44.4%, 57,1%, 88.8% and 73.3%, respectively (log-rank test, p = 0.001). The efficacy of treatment approaches for CNO depended on the severity of the disease. NSAID, methotrexate, and sulfasalazine were effective in forms without spine involvement, but pamidronate and TNF-a inhibitors were useful in vertebral forms of CNO. Pamidronate and TNF-a inhibitors more extensively suppressed CNO activity. The randomized controlled trials for assessment of the efficacy and safety of these medications is mandatory to confirm these results.
引用
收藏
页码:89 / 96
页数:7
相关论文
共 50 条
  • [1] Comparison of different treatment approaches of pediatric chronic non-bacterial osteomyelitis
    Kostik, Mikhail M.
    Kopchak, Olga L.
    Chikova, Irina A.
    Isupova, Eugenia A.
    Mushkin, Alexander Y.
    RHEUMATOLOGY INTERNATIONAL, 2019, 39 (01) : 89 - 96
  • [2] Chronic non-bacterial osteomyelitis in the jaw
    Kim, Soung Min
    Lee, Suk Keun
    JOURNAL OF THE KOREAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS, 2019, 45 (02) : 68 - 75
  • [3] Treatment Advances in Chronic Non-Bacterial Osteomyelitis and Other Autoinflammatory Bone Conditions
    Yongdong Zhao
    Ronald M. Laxer
    Polly J. Ferguson
    Current Treatment Options in Rheumatology, 2017, 3 (1) : 17 - 32
  • [4] Characteristics, Treatment Options, and Outcomes of Chronic Non-bacterial Osteomyelitis in Children
    Kraus, Raphael
    Laxer, Ronald M.
    CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2020, 6 (03) : 205 - 222
  • [5] Chronic Non-bacterial Osteomyelitis in Childhood - a Comprehensive Review
    Morbach, Henner
    Girschick, Hermann J.
    CURRENT RHEUMATOLOGY REVIEWS, 2013, 9 (01) : 17 - 21
  • [6] Chronic non-bacterial osteomyelitis masquerading as fibrous dysplasia
    Campbell, Tessa N.
    Frizzell, Bevan
    MacMullan, Paul
    MODERN RHEUMATOLOGY CASE REPORTS, 2020, 4 (02) : 192 - 195
  • [7] Chronic non-bacterial osteomyelitis and immune checkpoint molecules
    Ummusen Kaya Akca
    Erdal Sag
    Busra Aydın
    Nur Kubra Tasdemir
    Muserref Kasap Cuceoglu
    Ozge Basaran
    Ezgi Deniz Batu
    Yelda Bilginer
    Seza Ozen
    Clinical Rheumatology, 2024, 43 (1) : 553 - 560
  • [8] The impact of sarcopenia on the progression of chronic non-bacterial osteomyelitis
    Daniel Vogele
    Janine Akbulut
    Franziska Müller-Reichart
    Aleš Janda
    Henner Morbach
    Hermann J. Girschick
    Matthias C. Schaal
    Meinrad Beer
    Clemens Benoit
    Insights into Imaging, 16 (1)
  • [9] Retrospective Analysis of Children with Chronic Non-bacterial Osteomyelitis
    Akca, Ummusen Kaya
    Bayindir, Yagmur
    Bilginer, Yelda
    JOURNAL OF BEHCET UZ CHILDRENS HOSPITAL, 2023, 13 (01): : 23 - 29
  • [10] Dealing with Chronic Non-Bacterial Osteomyelitis: a practical approach
    Taddio, Andrea
    Ferrara, Giovanna
    Insalaco, Antonella
    Pardeo, Manuela
    Gregori, Massimo
    Finetti, Martina
    Pastore, Serena
    Tommasini, Alberto
    Ventura, Alessandro
    Gattorno, Marco
    PEDIATRIC RHEUMATOLOGY, 2017, 15